MedPath

Impact of high flow oxygen therapy on outcomes of COVID-19 patients

Not Applicable
Completed
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028634
Lead Sponsor
Rajendra Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
114
Inclusion Criteria

Confirm COVID- 19 positive patients.

Acute Hypoxemic respiratory failure (P/F ratio <300) or O2 saturation <90% with respiratory rate >25 breaths per minute with respiratory distress

Exclusion Criteria

Intubation prior to HFNOT

Shock (MAP <65 mm of Hg, SBP <90 mm of Hg)

Requirement of vasopressor infusion

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath